Patents by Inventor Elmar Wadenstorfer

Elmar Wadenstorfer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Solid Dosage Form of Olmesartan Medoxomil and Amlodipine
    Publication number: 20160129008
    Abstract: The invention relates to a stable solid dosage form comprising olmesartan medoxomil and amlodipine or a pharmacologically acceptable salt thereof. In particular, it relates to solid dosage forms free from reducing sugars. The stable solid dosage form may optionally further comprise hydrochlorothiazide or a pharmacologically acceptable salt thereof.
    Type: Application
    Filed: June 9, 2015
    Publication date: May 12, 2016
    Applicant: Daiichi Sankyo Company, Limited
    Inventors: Wolfgang Bauer, Johann Lichey, Andreas Teubner, Elmar Wadenstorfer
  • Solid Dosage Form of Olmesartan Medoxomil And Amlodipine
    Publication number: 20090175942
    Abstract: The invention relates to a stable solid dosage form comprising olmesartan medoxomil and amlodipine or a pharmacologically acceptable salt thereof. In particular, it relates to solid dosage forms free from reducing sugars. The stable solid dosage form may optionally further comprise hydrochlorothiazide or a pharmacologically acceptable salt thereof.
    Type: Application
    Filed: March 11, 2009
    Publication date: July 9, 2009
    Applicant: DAIICHI SANKYO COMPANY, LIMITED
    Inventors: Wolfgang Bauer, Johann Lichey, Andreas Teubner, Elmar Wadenstorfer
  • Percutaneous/transdermal delivery of ASA and antithrombotic therapies based thereon
    Patent number: 5900412
    Abstract: Topically applicable pharmaceutical/therapeutic alcoholic solution compositions, well suited for percutaneous/transdermal antithrombotic therapy, comprise an effective antithrombotic amount of acetylsalicylic acid ("ASA") or salt thereof, formulated into primary alcohol (e.g., isopropanol) and secondary ester (e.g., isopropyl myristate) solvents therefor, optionally in the presence of penetration enhancers and/or ASA hydrolysis inhibitors.
    Type: Grant
    Filed: April 25, 1997
    Date of Patent: May 4, 1999
    Assignee: Luitpold Pharma GmbH
    Inventors: Jurgen Traue, Andreas Teubner, Elmar Wadenstorfer